Browsing Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper by Subject "177Lu-octreotate"
Now showing items 1-4 of 4
-
Biomarker discovery and assessment for prediction of kidney response after 177Lu-octreotate therapy
(2014-11-28)Patients suffering from neuroendocrine tumors are oftentimes presented with spread disease at the time of diagnosis. Therapy using somatostatin analogs is today the only potentially curative treatment option for these ... -
Förbättrad radionuklidterapi av neuroblastom
(2023-04-26)Today, about half of the children diagnosed with high-risk neuroblastoma (HR-NB) survive due to considerable treatment improvements during the last decades. However, there is still much to be done for the other half who ... -
Multiparametric MRI for evaluation of tumour treatment response
(2016-11-18)Clinical assessment of tumour response to treatment largely relies on estimates of tumour size by, e.g., measuring the largest tumour diameters on magnetic resonance (MR) or computed tomography (CT) images, weeks or ... -
Strategies for optimisation of 177Lu-octreotate therapy – exploring local administration and combination therapy regimens
(2019-04-12)Neuroendocrine tumours (NETs) are a group of heterogeneous tumour types that originate in hormone-producing organs. Patients with NETs are often diagnosed after the primary tumour has metastasised. One treatment option for ...